TWELVE-WEEK MULTICENTER OPEN-LABEL RANDOMIZED COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF METHOTREXATE AS A CONCENTRATED SOLUTION FOR SUBCUTANEOUS ADMINISTRATION AND AS 15-MG TABLETS PER WEEK FOR RHEUMATOID ARTHRITIS

MLA

Yu. V. Muravyev, et al. “Twelve-Week Multicenter Open-Label Randomized Comparative Study of the Efficacy and Safety of Methotrexate as a Concentrated Solution for Subcutaneous Administration and as 15-Mg Tablets per Week for Rheumatoid Arthritis.” Научно-Практическая Ревматология, vol. 54, no. 2, July 2016, pp. 175–82. EBSCOhost, https://doi.org/10.14412/1995-4484-2016-175-182.

APA

Yu. V. Muravyev, V. I. Mazurov, & E. L. Nasonov. (2016). Twelve-Week Multicenter Open-Label Randomized Comparative Study of the Efficacy and Safety of Methotrexate as a Concentrated Solution for Subcutaneous Administration and as 15-Mg Tablets per Week for Rheumatoid Arthritis. Научно-Практическая Ревматология, 54(2), 175–182. https://doi.org/10.14412/1995-4484-2016-175-182

Chicago

Yu. V. Muravyev, V. I. Mazurov, and E. L. Nasonov. 2016. “Twelve-Week Multicenter Open-Label Randomized Comparative Study of the Efficacy and Safety of Methotrexate as a Concentrated Solution for Subcutaneous Administration and as 15-Mg Tablets per Week for Rheumatoid Arthritis.” Научно-Практическая Ревматология 54 (2): 175–82. doi:10.14412/1995-4484-2016-175-182.